Original Source(s)
Related Content
FDA raises TMB threshold for pembrolizumab
Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.
by Mouj Hijazi
October 23, 2026
-
3 min
Liquid Biopsy Predicts Early Lung Cancer Relapse
Whole-genome sequencing of circulating tumor DNA could identify patients at risk of recurrence more than a year before conventional imaging
November 2, 2026
-
3 min
Cryptococcal cellulitis may lead to amputation
A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.
October 26, 2026
-
4 min
